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Abstract: In this study, genipin-cross-linked collagen/chitosan
biodegradable porous scaffolds were prepared for articular
cartilage regeneration. The inﬂuence of chitosan amount and
genipin concentration on the scaffolds physicochemical prop-
erties was evaluated. The morphologies of the scaffolds were
characterized by scanning electron microscope (SEM) and
cross-linking degree was investigated by ninhydrin assay.
Additionally, the mechanical properties of the scaffolds were
assessed under dynamic compression. To study the swelling
ratio and the biostability of the collagen/chitosan scaffold,
in vitro tests were also carried out by immersion of the scaf-
folds in PBS solution or digestion in collagenase, respec-
tively. The results showed that the morphologies of the
scaffolds underwent a ﬁber-like to a sheet-like structural
transition by increasing chitosan amount. Genipin cross-
linking remarkably changed the morphologies and pore
sizes of the scaffolds when chitosan amount was less than
25%. Either by increasing the chitosan ratio or performing
cross-linking treatment, the swelling ratio of the scaffolds
can be tailored. The ninhydrin assay demonstrated that the
addition of chitosan could obviously increase the cross-link-
ing efﬁciency. The degradation studies indicated that geni-
pin cross-linking can effectively enhance the biostability of
the scaffolds. The biocompatibility of the scaffolds was eval-
uated by culturing rabbit chondrocytes in vitro. This study
demonstrated that a good viability of the chondrocytes
seeded on the scaffold was achieved. The SEM analysis has
revealed that the chondrocytes adhered well to the surface
of the scaffolds and contacted each other. These results sug-
gest that the genipin-cross-linked collagen/chitosan matrix
may be a promising formulation for articular cartilage scaf-
folding. VC 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A:
95A: 465–475, 2010.
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INTRODUCTION
Articular cartilage (AC) has a limited capacity for self-regen-
eration upon damage caused by traumatic injuries or degen-
erative diseases. This feature of AC can be attributed to its
characteristic avascular structure and relatively low cellular
metabolic activity.1,2 Many techniques have been employed
to treat articular cartilage defect, such as microfracture,
multiple drilling and arthroscopic lavage with or without
corticosteroids, and so on.3 But only a few of such treat-
ments were able to achieve satisfactory clinical results as
compared to autografts or allografts.4 Most of them had lim-
ited success to produce long-lasting hyaline cartilage.5
In recent years, tissue engineering has been introduced as
a promising approach for the regeneration of damaged
AC.6 The basic principle of tissue engineering on AC is
to seed the chondrocytes or differentiated stem cells in bio-
compatible and biodegradable scaffolds such as poly(lactic
acid) or poly(glycolic acid), and then implant the cell/
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scaffold construct in the joint defect. Many efforts have
been made to develop scaffolds with porous interconnected
network structure and proper mechanical strength to sup-
port the cells’ attachment, proliferation and differentiation
toward repairing the AC defect.7,8
Many biomaterials, including naturally occurring and
synthetic polymers or their combinations, have been exten-
sively investigated as potential AC tissue engineering scaf-
folds both in vitro or in vivo.9–14 Among these biomaterials,
collagen has received great attention, because it is the main
component of AC speciﬁc extracellular matrix (ECM) which
is reported to play important role in maintaining the chon-
drocytic phenotype and supporting the chondrogenesis both
in vitro and in vivo.15 As the main constituent in AC, colla-
gen can maintain the chondrocyte phenotype and glycosami-
noglycans (GAGs) production.16–18 Furthermore, collagen is
known as a most promising biomaterial in tissue engineer-
ing due to its excellent biocompatibility and low antigenic-
ity.19 However, the major drawbacks such as the rapid deg-
radation and poor mechanical properties limit its further
applications in tissue engineering. Cross-linking treatment
or blending with other materials is an efﬁcient method to
overcome these constraints. Nowadays, there are two kinds
of methods proposed in the cross-linking of collagen: chemi-
cal and physical methods.20 Although physical methods can
avoid introduction of potential toxic residuals, they cannot
yield high cross-linking degree. Therefore, the chemical
cross-linking treatment is still the dominant choice.21–23
Numerous chemical reagents have been employed to cross-
link collagen-based materials, including glutaraldehyde,
formaldehyde, diisocyanate, diepoxide, and 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide.22,24,25 Recently, a natu-
rally occurring cross-linking reagent genipin has received an
increasing interest in biomedical applications.26,27 Extensive
studies have been performed by Sung’s group and they found
that genipin not only has exhibited low cytotoxicity as com-
pared to glutaraldehyde and epoxy, but also was able to efﬁ-
ciently cross-link cellular tissues and biomaterials containing
primary amino groups.28–30 The use of genipin in cross-link-
ing collagen for AC tissue engineering could be an attractive
alternative to the traditional cross-linking reagents.
On the other hand, chitosan is also a natural and biode-
gradable polymer and has been widely applied in various
biomedical applications, such as wound healing, cartilage
and bone regeneration and drug delivery.31,32 Chitosan and
glycosaminoglycans (GAGs) share some structural character-
istics.33 Taking into account the important roles of GAGs in
stimulation of chondrogenesis, it seems a logical strategy to
fabricate scaffolds by using GAGs or GAG analogs for carti-
lage tissue engineering. In addition, the strong interactions
between collagen and chitosan molecular chains can make
them to form a stable complex and reach a molecular level
miscibility.34 Moreover, chitosan can act as cross-linking
bridge to increase the cross-linking efﬁciency of the colla-
gen-based scaffolds due to the abundant amino groups in
its main chains.20 Based on the previous investiga-
tion,16,24,26 the mixture of collagen and chitosan can be a
promising candidate matrix for AC scaffolding.
In this study, genipin-cross-linked collagen/chitosan
porous scaffolds were prepared for AC regeneration applica-
tions. The inﬂuence of chitosan amount and different con-
centrations of genipin on the physicochemical properties of
the scaffolds were investigated. The morphology and pore
size, cross-linking degree, swelling capacity, in vitro enzyme
degradation and dynamic mechanical properties of the
prepared collagen/chitosan scaffolds were characterized.
Finally, cytotoxicity of collagen/chitosan scaffolds was
screened by culturing New Zealand White Rabbit chondro-
cytes into the scaffolds until 12 days in vitro. The viability
and morphology of the chondrocytes were examined by per-
forming an 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide (MTT) assay and scanning electron micro-
scope (SEM) analysis, respectively.
MATERIALS AND METHODS
Materials
Chitosan (Mv ¼ 1.0  105 and deacetylation degree of
92.5%) was purchased from Sanland-Chem International
(China). Collagenase type I (125 U/mg) was purchased from
Sigma. Genipin was purchased from Wako (Japan). Pepsin
(3000 U/mg) was purchased from Amresco. All other
reagents and solvents were analytical grade and used as
received.
Collagen type I was digested from bovine tendon (from
slaughterhouse) by pepsin as previously described with
minor modiﬁcations.34,35 Brieﬂy, the bovine tendon was
defatted and freed from adhering noncollagen materials
before cut into small pieces. After digestion in pepsin solu-
tion for 72 h, the acetic acid (0.5 M) dissolved collagen solu-
tion was separated by centrifugation. Then, the supernatant
collagen solution was precipitated by adding 1 mol/L NaCl
solution. The precipitate was dialyzed and re-dissolved in
acetic acid. Collagen was puriﬁed by repeating the precipita-
tion and dialysis procedures. Finally, the puriﬁed collagen
was frozen at 20C and lyophilized in a freeze dryer
(ALPHA 2-4, Christ, Germany).
Preparation of collagen/chitosan scaffolds
The dried collagen or chitosan was dissolved in 0.2 M acetic
acid solution to prepare a 0.6% (w/v) solution, respectively.
The collagen and chitosan composites were prepared by
mixing the two solutions at different ratios: 1:0; 9:1; 3:1;
1:1 (collagen:chitosan). The composite solutions were
poured into the 6-well plates and the solution volume was
controlled to keep the height of the solution about 5 mm in
each well. Then, the solutions were kept in a saline bath
(30 wt % calcium chloride) at 20C for 10 h, and lyophi-
lized in a freeze dryer (ALPHA 2-4, Christ, Germany) to
obtain the porous scaffold. The collagen/chitosan scaffolds
containing 0, 10, 25, and 50% chitosan amount were named
as Col, Col/Cht-10, Col/Cht-25, and Col/Cht-50, respectively.
To remove the residual acetic acid, the fabricated colla-
gen/chitosan scaffolds were immersed in gradient ethanol
solution ranging from 100% to 0% (100, 80, 50, 30, and
0%) for 2 h in each concentration, respectively. Then, the
scaffolds were placed in the 6-well cell culture plate with
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each scaffold occupying a single well. Different concentra-
tion of genipin solutions (0.1, 0.3, and 0.5%, w/v) were pre-
pared by dissolving genipin in phosphate buffer saline solu-
tion (PBS, pH 7.4, Sigma). Then, 4 mL of the genipin
solution was added into each well and maintained for 24 h
at room temperature. Finally, the genipin-cross-linked colla-
gen/chitosan scaffolds were obtained by washing with
deionized water; the scaffolds were frozen at 20C and
lyophilized once again.
Morphology observation
The cross-section morphology of the collagen/chitosan scaf-
folds were observed by scanning electron microscopy (30XL
FEG, Philips, Netherlands). The samples were sputter-coated
with a layer of gold before observation, as previously
described elsewhere.2
Cross-linking degree determination
The cross-linking degree of the genipin-cross-linked colla-
gen/chitosan scaffolds was determined by ninhydrin assay
and was deﬁned as the ratio of the consumed amino groups
in the cross-linked samples to the free amino groups in the
corresponding uncross-linked samples.35 The test samples
were ﬁrst lyophilized for 24 h and then weighed. Subse-
quently, the test sample was heated with ninhydrin solution
for 20 minutes at 100C. The amount of free amino groups
in the test sample was determined by the optical absorb-
ance of the solution at 570 nm recorded with a spectropho-
tometer (Model UV-3802; Unico Corp., Shanghai, China)
using glycine at different concentrations (1.0, 2.0, 3.0, 4.0,
and 5.0 mg/mL) as standard. After heating with ninhydrin,
the amount of free amino groups in the tested samples is
proportional to the optical absorbance of the solution.
Swelling ratio test
The swelling ratio test was carried out as follows. Dry scaf-
folds were weighed (w0) at ﬁrst, and then hydrated in PBS
for 3 h at room temperature. After remove the excess sur-
face water with ﬁlter paper, the wet scaffolds were weighed
(w) again. The swelling ratio of the scaffolds was deﬁned as
the wet weight increase (w-w0) to the initial weight (w0).
The uncross-linked scaffolds with different chitosan amount
were set as the controls for the corresponding cross-linked
scaffolds.
In vitro collagenase degradation
The biodegradability of the collagen/chitosan scaffolds was
determined by incubating each sample in l mL PBS (pH 7.4)
containing 100 lg collagenase type I (12.5 units) at 37C
for 12 h. The degradation was discontinued by adding 100
lL 0.2 M ethylenediaminetetraacetic acid (EDTA) and cool-
ing the assay mixture in an ice bath immediately.36 The
resulting mixture was centrifuged at 3000 rpm for 10
minutes. Then, the supernatant was hydrolyzed in 6 M HCl
at 110C for 24 h. The ultraviolet spectroscopy absorbance
of hydroxyproline was examined according to the Woessner
method.37 The biodegradation degree is deﬁned as the ratio
of hydroxyproline content in the degraded matrix to that in
uncross-linked matrices.
Dynamic mechanical analysis (DMA)
The viscoelastic measurements were performed using a TRI-
TEC8000B DMA from Triton Technology (UK), equipped
with the compressive mode. The measurements were car-
ried out at 37C. Samples were cut in cylindrical shapes
with 4 mm diameter and 3 mm thickness (measured accu-
rately for each sample via a digital micrometer with preci-
sion of 0.001 mm before the test). Scaffolds were always an-
alyzed by immersing in a liquid bath (PBS, pH 7.4, Sigma)
placed in a TeﬂonV
R
reservoir. Scaffolds were previously
immersed in a PBS solution until equilibrium was reached
(overnight). The geometry of the samples was then meas-
ured and the samples were clamped in the DMA apparatus
and immersed in the PBS solution. After equilibration at
37C, the DMA spectra were obtained during a frequency
scan between 0.1 and 15 Hz. The experiments were per-
formed under constant strain amplitude (70 lm). A small
preload was applied to each sample to ensure that the
entire scaffold surface was in contact with the compression
plates before testing and the distance between plates was
equal for all scaffolds being tested. Three samples were
used per condition.
Isolation and culture of chondrocytes
The isolation of the chondrocytes was performed according
to the Guide for the Care and Use of Laboratory Animals
setting by National Institute of Health standards.
Chondrocytes were isolated from the femoral condyles
and femoral heads of New Zealand White rabbits by enzy-
matic digestion. Brieﬂy, the cartilage was collected in slices
using a scalpel. Then, the slices were subjected to collage-
nase type II (Sigma) digestion.10 The obtained chondrocytes
were cultured in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) containing: 10% fetal bovine serum (FBS), vitamin
C, 100 U/mL penicillin-streptomycin, and 25 lg/mL L-ascor-
bic acid. Cultures were maintained in an incubator (5% CO2
and 99% humidity) at 37C. The culture medium was
changed every 3 days.
The second passage chondrocytes and the Col/Cht-50
(cross-linked by 0.3% genipin) scaffolds were used in pres-
ent study. The scaffolds were punched into cylinders (6 mm
in diameter and 5 mm in height), and sterilized with epoxy
ethane. The scaffolds were pre-wetted in the culture me-
dium overnight and then put in the 48-well culture plate
before cell seeding. Then, 100 lL of the chondrocyte sus-
pension were seeded per scaffold (5  105 cells/scaffold).
The scaffolds were gently compressed by forceps to allow
the cells suspension to absorb into the inner part of the
scaffold. The scaffolds were transferred to another 48-well
culture plate after 4 h of cell seeding. The culture medium
in the plate was changed in 24 h for the ﬁrst time and
changed every 3 days after the ﬁrst change. Cultures were
maintained in a humidiﬁed incubator with 5% CO2 at 37C.
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Cell morphology and viability assay
To observe the chondrocytes adhesion and proliferation
onto the scaffolds, the scaffolds were washed with PBS then
ﬁxed in 2.5% glutaraldehyde for 24 h at the end of the 12
days of culturing. The constructs were gradually dehydrated
in a series of ethanol solutions, and then isoamyl acetate
was used to completely eliminate the ethanol. Samples were
dried in a critical point dryer (HCP-2, Hitachi, Japan) then
sputter coated with gold before examination under the SEM
(30XL FEG, Philips, Netherlands).
Cell viability was analyzed via 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT) assay every 3
days. At ﬁrst, the culture medium was removed, subse-
quently 300 lL MTT (1 mg/mL) solution and then 700 lL
of culture medium was added to the cells. After 4 h, the MTT
solution and the culture medium were removed, and then
700 lL dimethylsulphoxide (DMSO) solution was added and
kept for 10 minutes. In the end, the DMSO solution was
transferred to the 96-well cell culture plate and measured by
a microplate reader (Sunrise-Basic Tecan) at 492 nm. The
scaffolds without cells seeding were used as controls.
Statistical analysis
Experiments were repeated three times and results
expressed as an mean 6 standard deviation. The swelling ra-
tio, cross-linking degree, enzymatic degradation tests and MTT
test were evaluated by one-way analysis of variance (ANOVA).
A comparison between two means was analyzed using
Tukey’s test with statistical signiﬁcance set at p < 0.05.
RESULTS AND DISCUSSION
Morphology of scaffolds
Figure 1 shows the cross-sectional morphology of the
uncross-linked and genipin-cross-linked collagen/chitosan
scaffolds with different chitosan amounts. All scaffolds pos-
sessed a three-dimensional interconnected macroporous
structure. The ﬁber- and strip-like structure of collagen scaf-
fold with pore size ranged from 100 to 200 lm is presented
in Figure 1(a). It is consistent with the triple-helix structure
of collagen which imparts Col scaffold with the ﬁbrous mor-
phology. It can be found that the Col/Cht-10 and Col/Cht-25
scaffolds displayed a sheet-like structure instead of a ﬁber-
like structure, and their pore size decrease to about 50–150
lm [Fig. 1(c,e)]. The explanation for this observation can be
related with the fact that chitosan is a semi-crystal polymer
and it tends to form the membrane structure.24 With low
chitosan amount, the scaffolds would form many small
pieces of sheets which lead to the slightly decrease in pore
size. While being immersed in genipin solution, the collagen
scaffold would be cross-linked and rehydrated at the same
time. The latter procedure would lead to the collapse of the
porous structure and the fusion of the ﬁbers before genipin
can play its role. For this reason, the collagen ﬁber formed a
typical membrane-like structure and with pore size lower
than 100 lm after undergoing the cross-linking step [Fig.
1(b)]. The cross-linked Col/Cht-10 scaffold consisted of lat-
tice-like structure with pore size between 100 and 150 lm
[Fig. 1(d)]. As the chitosan amount increased to 25%, the
lattices become ordered and its size increased with pore
size ranging from 150 lm to 200 lm [Fig. 1(f)]. During the
cross-linking procedure, scaffolds with higher chitosan con-
tent had more cross-linking points, so the small sheets
would be linked together to form larger sheets and inducing
the formation of larger pores after re-lyophilization.
It is noticed that honeycomb-like ordered structure with
large pore walls and pore size ranged from 100 to 200 lm
were evident in the Col/Cht-50 scaffolds [Fig. 2(a)]. When
chitosan amount increased to 50%, the chitosan in the scaf-
folds can form continuous and large pieces of sheets which
led to the observed larger pore wall structure and larger
pore size compared to the uncross-linked Col, Col/Cht-10
and Col/Cht-25. There were no obvious changes in the pore
size and morphology of the Col/Cht-50 scaffolds after cross-
linking with different concentration of genipin [Fig. 2(b–d)].
Since chitosan possesses higher mechanical strength than
collagen, the Col/Cht-50 scaffold can retain its original
structure when cross-linked with genipin. For this reason
no collapse and fusion of the pores was observed in the
cross-linked scaffolds.
Cross-linking degree
Figure 3 displays the cross-linking degree of the collagen/chi-
tosan scaffolds. The cross-linking degree ranged from 63.93
to 74.14% when cross-linked by 0.3% genipin. The cross-
linking degree of Col/Cht-50 scaffolds ranged from 48.28 to
80.71% as genipin concentration increased from 0.1 to 0.5%.
These results demonstrated that genipin is a favorable
cross-linking reagent for collagen or/and chitosan, as it can
efﬁciently cross-link the amino groups even at low concen-
tration. Moreover, as the genipin concentration increased,
more and more amino groups were cross-linked which led
to a higher cross-linking degree.
Sung et al.38 reported that the amino acid residues
within collagen that can react with genipin were lysine,
hydroxylysine and arginine. This group39 also showed that
genipin can react with the amino groups in chitosan. Addi-
tionally, they both found that genipin can form intramolecu-
lar and intermolecular cross-linking networks. Therefore,
during the cross-linking treatment, collagen and chitosan
can cross-link with each other to form an interpenetrating
polymer network (IPN). It is well know that the ratio of
amino groups in chitosan molecular chain is much higher
than that in collagen molecular chain. Thus, the free amino
groups can act as the cross-linking points. As a result, the
amount of cross-linking points directly relate to the original
amount of free amino groups in the scaffolds. During the
cross-linking step, more cross-linking points will lead to
higher biostability. Therefore, we deduce that the addition
of chitosan can improve the biostability of collagen. This
issue will be further discussed in the following section.
Swelling ratio test
The water binding capacity of the scaffold plays an impor-
tant role in tissue regeneration. The swelling ratio of scaf-
folds with different chitosan amount (uncross-linked and
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cross-linked) is shown in Figure 4. We could ﬁnd that the
water-retention ability of the scaffolds increased by increas-
ing the chitosan amount, despite the cross-linked or the
uncross-linked scaffolds. The cross-linked scaffolds had a
higher swelling ratio as compared to the corresponding
uncross-linked ones.
The swelling ratio of the scaffold strongly depends on
the hydrophilic nature and microstructure of the scaffold.
Since collagen and chitosan are both hydrophilic materials,
the ability to retain the scaffold porous structure seems to
be the main explanation for the differences observed in the
swelling ratio. The poor mechanical properties of collagen
led to the collapse of the porous structure when it was
taken out from PBS solution. Contrarily, chitosan possesses
higher elasticity which is helpful for the retention of the
scaffold original porous structure. Hence, the swelling ratio
of the scaffolds increased as the increase of chitosan
amount in the scaffolds (Fig. 4).
It’s well known that the swelling or hydrophilic property
of the materials would decrease after cross-linking treat-
ment, as the reduction of the hydrophilic groups (such as
the amino or carboxylic groups) which are consumed during
the cross-link reaction. However, in our case, the swelling
ratio of the cross-linked scaffolds was higher than that of
FIGURE 1. The cross-section SEM images of uncross-linked and 0.3% genipin cross-linked collagen/chitosan scaffolds. (a), (c), and (e) represent
the morphology of the Col, Col/Cht-10, Col/Cht-25 scaffolds, respectively; (b), (d), and (f) display the morphology of the 0.3% genipin cross-linked
collagen/chitosan scaffolds corresponding to (a), (c), and (e), respectively.
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FIGURE 2. The cross-section SEM images of the Col/Cht-50 scaffolds cross-linked via different concentration of genipin. (a) Control; (b) 0.1%
genipin; (c) 0.3% genipin; and (d) 0.5% genipin.
FIGURE 3. The cross-linking degree of collagen/chitosan scaffolds
with different chitosan amount and being cross-linked via different
genipin concentration. * indicates statistical signiﬁcance when com-
pared with 0.1% genipin cross-linked Col/Cht-50 scaffold (p < 0.05)
and # indicates statistical signiﬁcance when compared with 0.3% gen-
ipin cross-linked collagen scaffold (p < 0.05).
FIGURE 4. The swelling ratio of the uncross-linked and cross-linked
(0.3% genipin) collagen/chitosan scaffolds with different chitosan
amount. * indicates statistical signiﬁcance when compared with the
corresponding controls (uncross-linked scaffolds) (p < 0.05). # and &
indicate statistical signiﬁcance when compared with the cross-linked
Col and Col/Cht-10 scaffolds, respectively (p < 0.05).
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the corresponding uncross-linked scaffolds (Fig. 4). Our ex-
planation is that, under hydration conditions, the collapse of
the porous structure was inevitable in the case of uncross-
linked scaffolds, but the cross-linking treatment can enhance
the scaffolds’ structural stability and subsequently increased
the scaffold water-retention ability.
The swelling ratio of the Col/Cht-50 scaffolds seemed to
slightly decrease as the genipin concentration increased
from 0.1 to 0.5%, but they were signiﬁcant higher than that
of the uncross-linked scaffolds (Fig. 5).
Genipin can efﬁciently cross-link the scaffold by the
reaction with amino groups.27 The Col/Cht-50 scaffolds con-
tain the highest ratio of amino groups as compared to the
Col, Col/Cht-10 and Col/Cht-25 scaffolds. Therefore, the
Col/Cht-50 scaffold cross-linked by genipin can keep its
original porous structure, which led to the higher swelling
ratio than the control. Since all the cross-linked Col/Cht-50
scaffolds presented similar morphology and pore size
(Fig. 2) and favorable biostability (Fig. 6), we hypothesize
that the hydrophilic groups left in the scaffold played the key
role on the scaffolds swelling ability. But there were no sig-
niﬁcant differences in the swelling ratio of the Col/Cht-50
scaffolds cross-linked via different genipin concentration.
In vitro biodegradability
The in vitro enzymatic degradation properties of the colla-
gen/chitosan scaffolds under uncross-linked or cross-linked
treatment are shown in Figure 6. Collagen in all of the
uncross-linked collagen/chitosan scaffolds were completely
digested after incubated in collagenase type I solution for
12 h. The addition of chitosan did not affect the degradation
of collagen in the uncross-linked scaffolds.
After performing the cross-linking treatment with 0.3%
genipin solution for 24 h, the anti-degradation ability of col-
lagen enhanced remarkably. There was only 10.71% degra-
dation in the pure collagen scaffold. Furthermore, the addi-
tion of chitosan greatly improved the enzymatic stability of
collagen. The degradation ratio of collagen in the scaffolds
decreased as increasing chitosan amount. The degradation
ratio of collagen in Col/Cht-50 scaffold was only 1.45%.
The inﬂuence of genipin concentration on the degrada-
tion of Col/Cht-50 scaffolds is shown in Figure 7. Collagen
degradation decreased by increasing the genipin concentra-
tion. After cross-linking with 0.5% genipin, the degradation
degree of collagen was below 1%.
These results indicated that genipin can effectively
cross-link collagen, thus improving its enzymatic stability;
meanwhile the presence of chitosan can dramatically
FIGURE 5. The swelling ratio of the Col/Cht-50 scaffolds cross-linked via
different genipin concentration. * indicates statistical signiﬁcance when
compared with control (uncross-linked Col/Cht-50 scaffold) (p < 0.05).
FIGURE 6. The degradation degree of the uncross-linked and cross-
linked (0.3% genipin) collagen/chitosan scaffolds with different chito-
san amount after digestion in 100 lg/mL (12.5 units) collagenase type
I for 12 h. * indicates statistical signiﬁcance when compared with cor-
responding controls (uncross-linked scaffolds) (p < 0.05). # indicates
statistical signiﬁcance when compared with cross-linked Col (p <
0.05). $ indicates statistical signifsicance when compared with cross-
linked Col/Cht-10 and Col/Cht-25 (p < 0.05).
FIGURE 7. The degradation degree of the Col/Cht-50 scaffolds cross-
linked via different genipin concentration after digestion in 100 lg/mL
(12.5 units) collagenase type I for 12 h. *, & and $ indicate statistical
signiﬁcance when compared with control, 0.1% and 0.3% genipin
cross-linked scaffolds, respectively (p < 0.05).
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increase the cross-link efﬁciency. It has been shown40 that
collagenase induces collagen degradation via cleaving the
peptide bonds between leucine and glycine triple-helical col-
lagen. The intramolecular and intermolecular cross-linking
network on collagen or collagen/chitosan scaffolds hinders
the collagenase to access the cleavage sites in collagen. For
this reason the cross-linked scaffolds presented a higher
biostability. On the other hand, the cross-linking sites
depend on the amount of amino groups available. Therefore,
the cross-linked Col/Cht-50 scaffolds displayed signiﬁcant
enhancement in collagen biostability compared to that of
the cross-linked Col/Cht-10 and Col/Cht-50 scaffolds.
We also noticed an interesting phenomenon when corre-
lating the biostability and the cross-linking degree data. The
scaffolds with very different cross-linking degrees but
shared nearly the same biostability. For example, the cross-
linking degrees of the 0.1% genipin-cross-linked Col/Cht-50
scaffolds and the 0.3% genipin-cross-linked Col/Cht-10 scaf-
folds were 48.28 and 73.74%, respectively (Fig. 3). However,
the enzymatic degradation of these two groups was both
about 3.2% (Figs. 6 and 7). The explanation for this can be
related to the different amount of original amino groups
presented in these two groups’ samples. The Col/Cht-50
scaffolds possess more original free amino groups than the
Col/Cht-10 scaffolds. With no doubt, the abundant amino
groups in Col/Cht-50 will bring about more cross-linking
points even at low genipin concentration.
Dynamic mechanical analysis (DMA) test
Dynamic mechanical analysis (DMA) is an adequate tool to
characterize the mechanical/viscoelastic properties of poly-
meric materials. It has been reported that41,42 polymeric
materials present different behaviors depending on the kind
of environment where they are tested. Since articular carti-
lage often bears a dynamic compression force, DMA experi-
ments were performed in a hydrated environment and at
37C to assess how scaffolds behave in more realistic
conditions.42,43
Figure 8 presents the viscoelastic behavior of the scaf-
folds with different chitosan amount being all cross-linked
by 0.3% genipin. The storage modulus (E0) of all the scaf-
folds tends to increase by increasing the frequency
FIGURE 8. (a) Storage modulus (E0) and (b) loss factor (tan d) of 0.3% genipin cross-linked collagen/chitosan scaffolds with different chitosan
amount measured by immersing the samples in PBS at 37C.
FIGURE 9. (a) Storage modulus (E0) and (b) loss factor (tan d) of Col/Cht-50 scaffolds cross-linked via different genipin concentration measured
by immersing the samples in PBS at 37C.
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[Fig. 8(a)]. Furthermore, Figure 8(a) shows that E0 increased
from 2.4  105 to 4.6  105 Pa when chitosan amount
increased from 0 to 50%. However, although it showed an
initial higher value in E0, Col/Cht-50 presented less increase
in E0 as compared to Col/Cht-10 and Col/Cht-25 with the
increasing frequency. From Figures 1 and 2 we observed
that the pore size increase with the increase of chitosan
amount and Figure 4 shows that a higher swelling ratio was
veriﬁed for Col/Cht-50 but, in Figure 3 a higher cross-link-
ing degree was veriﬁed. Moreover, the larger pore wall and
the ordered honeycomb-like structure of Col/Cht-50 can
lead to a retention of PBS in the pores where the deform-
ability of the scaffolds are more difﬁcult due to a hydro-
static effect leading to a not so pronounced increase in E0.44
The inﬂuence of chitosan amount on the loss factors
(tan d) is presented in Figure 8(b). Values typically higher
than 0.2 were observed, evidencing the clear viscoelastic na-
ture of the structures. It was observed that Col/Cht-10 and
Col/Cht-25 presented similar behaviors of tan d which were
distinct from that of Col and Col/Cht-50. Tan d of Col
slightly decreased with the increase of frequency indicating
its lower viscosity as compared to other groups. Tan d val-
ues of Col/Cht-10 and Col/Cht-25 increased with frequency
indicating their higher damping capabilities than that of the
other two groups. The tan d of Col/Cht-50 only increased
above 1 Hz. The large pore wall and ordered honeycomb-
like structure of Col/Cht-50 led to its superior PBS retention
ability conﬁrmed in Figure 4. Here the hydrostatic effect of
water entrapped within the pores lead to an increase of the
values of tan d.44
The variation of the viscoelastic properties by increasing
the genipin concentration for Col/Cht-50 scaffolds is pre-
sented in Figure 9. In Figure 9(a), we can observe that E0
increase with the increase of genipin concentration (2.7 
105 to 6.3  105 for f ¼ 0.1 Hz) promoting the stiffness of
the scaffolds.45,46 It is shown in Figure 2 that no noticeable
changes were observed in the morphologies and pore sizes
of the scaffolds by increasing the genipin concentration. In
Figure 3, an increase on the cross-linking degree was
observed by the increase in genipin concentration from 0.1
to 0.5%. Moreover, the swelling ratio was slightly decreased
with the increase of genipin concentration. All these data are
in agreement with the DMA results of Col/Cht-50. Figure
9(b) represents the variation of the loss factor (tan d) along
the frequency. The loss factor is the ratio of the amount of
energy dissipated by viscous mechanisms relative to energy
stored in the elastic component providing information about
the damping properties of the material. For all formulations,
tan d increases with the increase of frequency indicating that
the materials became more viscous and less elastic. Since all
the formulations are only different in the genipin concentra-
tion, the values of tan d are very similar to all although, 0.1%
genipin presented slightly higher values, which is ascribed to
the lower cross-linking degree.47
Cell viability and cell morphology
In this study, a MTT assay was carried out to measure the
relative viability of chondrocytes. Figure 10 displays the
FIGURE 10. The chondrocytes viability when cultured in Col/Cht-50
scaffolds. * indicates statistical signiﬁcance when compared with
MTT values of day 3 and day 6 (p < 0.05).
FIGURE 11. Morphology of chondrocytes seeded onto the surface of Col/Cht-50 scaffolds after 12 days of culturing, (a) on the surface of the
scaffold; (b) inside the scaffold.
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viability of chondrocytes seeded onto the 0.3% genipin
cross-linked Col/Cht-50 scaffolds. There was a signiﬁcant
improvement in MTT value as prolonging the culture time.
The MTT values were increased from 0.726 (day 3) to
1.446 (day 12). The increase of MTT value between day 6
and day 9 was the highest during the tested adjacent two
time periods. The continuous increasing of MTT values can
be related to the scaffolds noncytotoxic behavior and proved
that genipin treatment did not induce any deleterious effect
on cells viability. MTT values of the controls were nearly
unchanged and remained at a low level (Fig. 10). Thereby,
the blue color of the scaffolds introduced by genipin treat-
ment is stable and will not affect the MTT test. These
results revealed that the scaffolds were noncytotoxic and
beneﬁtted the viability of chondrocytes.
Figure 11 shows SEM images of chondrocytes grown in
the Col/Cht-50 scaffold after culturing for 12 days. It can be
observed that the cells spread on the surface of the pore
walls in the scaffold. The cells contacted each other by the
extended lamellipodial protrusions, which is an indication of
cell’s activation. It can be observed that the chondrocytes
presented ﬁbroblastic-like morphology [black arrows in
Fig. 11(a,b)] just as the morphology displayed in the 2D
culture in the cell culture plates before seeding in the scaffold
(data not shown). This image supports the idea that genipin-
cross-linked collagen/chitosan scaffolds promoted the attach-
ment and viability of chondrocytes and may serve as a suitable
3D matrix for cartilage tissue engineering applications.
CONCLUSIONS
In this study, we perform the physicochemical characteriza-
tion and preliminary assessment of the biological perform-
ance of genipin-cross-linked collagen/chitosan porous scaf-
folds. The SEM images conﬁrmed that the pore size and the
morphology of the scaffolds can be tailored by the varying
the amount of chitosan. Supported by the swelling data, we
found that the cross-linking treatment didn’t decrease the
PBS retention abilities of the collagen/chitosan scaffolds.
In vitro biodegradation demonstrated that the biostability of
the collagen in the cross-linked collagen/chitosan scaffolds
was improved. All the prepared collagen/chitosan porous
scaffolds presented elastic properties during DMA test; in
the case of Col/Cht-50, the elasticity modulus increased
with the increasing of genipin concentration. The in vitro
cell culture study demonstrated that the scaffolds displayed
suitable biocompatibility as it can support chondrocyte’s ad-
hesion, spread onto the surface and the inside of the scaf-
fold and, as well as chondrocyte’s viability. Therefore, the
genipin-cross-linked collagen/chitosan may be an interesting
formulation for further study as scaffolding in articular car-
tilage tissue engineering.
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